The Diagnostic Value of <sup>18</sup>F-Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography in Differentiated Thyroid Cancer Patients with Elevated Thyroglobulin/Thyroglobulin Antibody Levels and Negative Iodine Scintigraphy: A Systematic Review and Meta-Analysis-Reference-Cited by-同舟云学术

The Diagnostic Value of ¹⁸F-Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography in Differentiated Thyroid Cancer Patients with Elevated Thyroglobulin/Thyroglobulin Antibody Levels and Negative Iodine Scintigraphy: A Systematic Review and Meta-Analysis

Published:2023-10-01 Issue:10 Volume:33 Page:1224-1236
ISSN:1050-7256
Container-title:Thyroid®
language:en
Short-container-title:Thyroid®

Author:

Bang Ji-In¹,Park Sohyun²,Kim Keunyoung³^ORCID,Seo Youngduk⁴,Chong Ari⁵,Hong Chae Moon⁶^ORCID,Choi Miyoung⁷^ORCID,Lee Sang-Woo⁸,Oh So Won⁹^ORCID

Affiliation:

1. Department of Nuclear Medicine, CHA Bundang Medical Center, CHA University, Gyeonggi-do, Republic of Korea.

2. Department of Nuclear Medicine, National Cancer Center Hospital, Gyeonggi-do, Republic of Korea.

3. Department of Nuclear Medicine and Biomedical Research Institute, Pusan National University Hospital and School of Medicine, Pusan National University, Pusan, Republic of Korea.

4. Department of Nuclear Medicine, Chungnam National University Sejong Hospital, Sejong, Korea.

5. Department of Nuclear Medicine, College of Medicine, Chosun University, Gwangju, Korea.

6. Department of Nuclear Medicine, School of Medicine, Kyungpook National University, Daegu, Republic of Korea.

7. Division for Healthcare Technology Assessment Research, National Evidence-based Healthcare Collaborating Agency, Seoul, Korea.

8. Department of Nuclear Medicine, Kyungpook National University, School of Medicine and Chilgok Hospital, Daegu, Republic of Korea.

9. Department of Nuclear Medicine, Seoul National University Boramae Medical Center, Seoul, Republic of Korea.

Publisher

Mary Ann Liebert Inc

Subject

Endocrinology,Endocrinology, Diabetes and Metabolism

Link

https://www.liebertpub.com/doi/pdf/10.1089/thy.2023.0264

Reference44 articles.

1. Defining a rational step-care algorithm for managing thyroid carcinoma patients with elevated thyroglobulin and negative on radioiodine scintigraphy (TENIS): considerations and challenges towards developing an appropriate roadmap

2. Thyroid cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up

3. Thyroid Carcinoma, Version 2.2022, NCCN Clinical Practice Guidelines in Oncology

4. 2015 American Thyroid Association Management Guidelines for Adult Patients with Thyroid Nodules and Differentiated Thyroid Cancer: The American Thyroid Association Guidelines Task Force on Thyroid Nodules and Differentiated Thyroid Cancer

5. 2016 Revised Korean Thyroid Association Management Guidelines for Patients with Thyroid Nodules and Thyroid Cancer

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Diagnostic performance of 2-[18F]FDG PET/CT in recurrent differentiated thyroid cancer and elevated antithyroglobulin antibodies: an updated systematic review and bivariate meta-analysis;Endocrine;2024-09-09

2. 68Ga-FAPI-RGD PET/CT Detected Skull Metastasis Better Than 18F-FDG in a Patient With Radioiodine-Refractory Differentiated Thyroid Cancer;Clinical Nuclear Medicine;2024-05-31

3. Korean Thyroid Association Guidelines on the Management of Differentiated Thyroid Cancers; Part II. Follow-up Surveillance after Initial Treatment 2024;International Journal of Thyroidology;2024-05-30

4. Correction to: The Diagnostic Value of ¹⁸F-Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography in Differentiated Thyroid Cancer Patients with Elevated Thyroglobulin/Thyroglobulin Antibody Levels and Negative Iodine Scintigraphy: A Systematic Review and Meta-Analysis by Bang et al. Thyroid 2023;33(10):1224–1236; doi: 10.1089/thy.2023.0264;Thyroid®;2024-01-01

5. What Is the Diagnostic Role of FDG–PET/CT in Differentiated Thyroid Cancer Patients with Elevated Tumor Markers but Negative Whole-Body Scintigraphy?;Clinical Thyroidology®;2023-12-01